Human germinal center-associated lymphoma protein expression is associated with improved failure-free survival in Brazilian patients with classical Hodgkin lymphoma

Leukemia and Lymphoma

Volumn 50, Issue 11, 2009, Pages 1830-1836

  Azambuja, Denize ^a   Lossos, Izidore S ^b   Biasoli, Irene ^c,d   Morais, Jos Carlos ^c,d   Britto, Luciana ^c,d   Scheliga, Adriana ^a   Pulcheri, Wolmar ^c,d   Natkunam, Yasodha ^e   Spector, Nelson ^c,d  

^a Instituto Nacional de Cncer   (Brazil)

^b UNIVERSITY OF MIAMI   (United States)

^c Department of Medicine ^*  (Brazil)

^d FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HGAL; Hodgkin lymphoma; Prognosis; Survival; Tissue microarray

Indexed keywords

BLEOMYCIN; DACARBAZINE; DOXORUBICIN; VINBLASTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAZIL; CLASSICAL HODGKIN LYMPHOMA; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE; GERMINAL CENTER; HGAL GENE; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TISSUE MICROARRAY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; BRAZIL; COHORT STUDIES; DACARBAZINE; DOXORUBICIN; FEMALE; GERMINAL CENTER; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS; TISSUE ARRAY ANALYSIS; TREATMENT OUTCOME; VINBLASTINE; YOUNG ADULT;

EID: 71049191414     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428190903242628     Document Type: Article

References (12)

1. Diehl V, Fuchs M. Early, intermediate and advanced Hodgkin's lymphoma: modern treatment strategies. Ann Oncol 2007;18(Suppl 9):ix71-ix9.
2. Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med 1998;339:1506-1514.
3. Hsi ED. Biologic features of Hodgkin lymphoma and the development of biologic prognostic factors in Hodgkin lymphoma: tumor and microenvironment. Leuk Lymphoma 2008;49:1668-1680.
4. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-511.
5. Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002;346: 1937-1947.
6. Lossos IS, Alizadeh AA, Rajapaksa R, et al. HGAL is a novel interleukin-4-inducible gene that strongly predicts survival in diffuse large B-cell lymphoma. Blood 2003;101:433-440.
7. Natkunam Y, Lossos IS, Taidi B, et al. Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation. Blood 2005;105:3979-3986.
8. Natkunam Y, Hsi ED, Aoun P, et al. Expression of the human germinal center-associated lymphoma (HGAL) protein identifies a subset of classic Hodgkin lymphoma of germinal center derivation and improved survival. Blood 2007;109:298-305.
9. Stein HDG, Pileri SA, Weiss LM, et al. Classical Hodgkin lymphoma. Introduction. In: WHO classification of Tumors of Hematopoietic and Lymphoid Tissues, 4th edn. Lyon; 2008.
10. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998;4:844-847.
11. Schwering I, Brauninger A, Klein U, et al. Loss of the Blineage- specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 2003;101:1505-1512.
12. Lu X, Chen J, Malumbres R, et al. HGAL, a lymphoma prognostic biomarker, interacts with the cytoskeleton and mediates the effects of IL-6 on cell migration. Blood 2007;110:4268-4277.